Ford orders 12 ultra-cold freezers to distribute COVID-19 vaccines to employees
By Ben Klayman DETROIT (Reuters) - Ford Motor Co said on Tuesday it has ordered a dozen ultra-cold freezers that can safely store Pfizer Inc's COVID-19 vaccine, a move aimed at ensuring the U.S. automaker's workers have access to vaccines when they are rolled out nationally
COVID-19 vaccines to employees" src="https://images.firstpost.com/wp-content/uploads/reuters/11-2020/25/2020-11-24T155607Z_1_LYNXMPEGAN18S_RTROPTP_2_HEALTH-CORONAVIRUS-FORD-MOTOR-FREEZERS.jpg" alt="Ford orders 12 ultracold freezers to distribute COVID19 vaccines to employees" width="300" height="225" />
By Ben Klayman
DETROIT (Reuters) - Ford Motor Co said on Tuesday it has ordered a dozen ultra-cold freezers that can safely store Pfizer Inc's COVID-19 vaccine, a move aimed at ensuring the U.S. automaker's workers have access to vaccines when they are rolled out nationally.
Ford's purchase mirrors efforts by U.S. states and cities to buy equipment to store millions of doses of Pfizer's vaccine at temperatures of minus 70 Celsius (minus 94 Fahrenheit), significantly below the standard for vaccines of 2-8 C (36-46 F).
Health care providers and states are preparing for a new type of vaccines by Pfizer and Moderna Inc that require lower temperatures for storage.
"We're doing this so that we can make the vaccine available to our employees on a voluntary basis," Ford spokeswoman Kelli Felker said.
Details of how Ford will use the freezers, which are expected to be delivered by year end, are still being worked out, she said.
Assembly workers are considered essential in most states, but not at the top of the list for vaccines, which are expected to be distributed first to healthcare workers and nursing home residents.
Automakers have been largely able to avoid spread of the virus among hourly workers in their assembly plants after a two-month shutdown earlier in the year, but COVID-19 cases and hospitalizations are spiking in the United States, especially in the Midwest.
Felker did not know which company is supplying Ford with the freezers. Major manufacturers include Thermo Fisher Scientific Inc, PHC Corp of North America, Luxembourg's B Medical Systems, Stirling Ultracold and Helmer Scientific.
Some specialty freezer makers have warned of months-long waits for units.
Ford, which decided to buy the freezers on its own and is not working with other companies or states, did not disclose how much it spent, but the specialized freezers required by Pfizer's vaccine can cost $5,000 to $15,000 apiece, according to industry officials.
General Motors Co said it had not purchased freezers at this time. "We are taking steps to be prepared to make vaccines available to our employees when the time is right and vaccines are available to us," GM spokesman Patrick Morrissey said.
Officials at Toyota Motor Corp, Fiat Chrysler Automobiles and the United Auto Workers union, which represents most U.S. hourly workers at the Detroit automakers, did not have an immediate comment. Michigan state health officials could not immediately be reached to comment.
(Reporting by Ben Klayman; Editing by Lisa Shumaker; Editing by Chizu Nomiyama and Jonathan Oatis)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Uday Sampath Kumar (Reuters) - Target Corp reported a 17.2% rise in comparable sales for the holiday season on Wednesday as its online sales more than doubled, thanks to faster deliveries and higher demand for home goods, electronics and beauty products.
By Medha Singh and Devik Jain (Reuters) - The S&P 500 and the Nasdaq rose in choppy trading on Wednesday as Intel shares jumped thanks to a change in management while broader sentiment was muted after a recent run to record highs. Intel said it would replace Chief Executive Officer Bob Swan with VMware Inc CEO Pat Gelsinger next month
By Danny Ramos LA PAZ (Reuters) - The Bolivian government said on Wednesday it had signed a contract with India's Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine. President Luis Arce said that combined with a recent deal to buy 5.2 million Sputnik V vaccine doses from Russia, Bolivia now expected to be able to inoculate all of its vaccinable population. Both vaccines require two doses to be given, meaning they would be used to inoculate a total of 5.1 million people from Bolivia's 11.51 million-strong population.